Javascript must be enabled to continue!
A DNA repair player, ring finger protein 43, relieves etoposide‐induced topoisomerase II poisoning
View through CrossRef
AbstractRing finger protein 43 (RNF43) is an E3 ubiquitin ligase which is well‐known for its role in negative regulation of the Wnt‐signaling pathway. However, the function in DNA double‐strand break repairs has not been investigated. In this study, we used a lymphoblast cell line, DT40, and mouse embryonic fibroblast as cellular models to study DNA double‐strand break (DSB) repairs. For this purpose, we created RNF43 knockout, RNF43−/− DT40 cell line to investigate DSB repairs. We found that deletion of RNF43 does not interfere with cell proliferation. However, after exposure to various types of DNA‐damaging agents, RNF43−/− cells become more sensitive to topoisomerase II inhibitors, etoposide, and ICRF193, than wild type cells. Our results also showed that depletion of RNF43 results in apoptosis upon etoposide‐mediated DNA damage. The delay in resolution of γH2AX and 53BP1 foci formation after etoposide treatment, as well as epistasis analysis with DNAPKcs, suggested that RNF43 might participate in DNA repair of etoposide‐induced DSB via non‐homologous end joining. Disturbed γH2AX foci formation in MEFs following pulse etoposide treatment supported the notion that RNF43 also functions DNA repair in mammalian cells. These findings propose two possible functions of RNF43, either participating in NHEJ or removing the blockage of 5′ topo II adducts from DSB ends.
Title: A DNA repair player, ring finger protein 43, relieves etoposide‐induced topoisomerase II poisoning
Description:
AbstractRing finger protein 43 (RNF43) is an E3 ubiquitin ligase which is well‐known for its role in negative regulation of the Wnt‐signaling pathway.
However, the function in DNA double‐strand break repairs has not been investigated.
In this study, we used a lymphoblast cell line, DT40, and mouse embryonic fibroblast as cellular models to study DNA double‐strand break (DSB) repairs.
For this purpose, we created RNF43 knockout, RNF43−/− DT40 cell line to investigate DSB repairs.
We found that deletion of RNF43 does not interfere with cell proliferation.
However, after exposure to various types of DNA‐damaging agents, RNF43−/− cells become more sensitive to topoisomerase II inhibitors, etoposide, and ICRF193, than wild type cells.
Our results also showed that depletion of RNF43 results in apoptosis upon etoposide‐mediated DNA damage.
The delay in resolution of γH2AX and 53BP1 foci formation after etoposide treatment, as well as epistasis analysis with DNAPKcs, suggested that RNF43 might participate in DNA repair of etoposide‐induced DSB via non‐homologous end joining.
Disturbed γH2AX foci formation in MEFs following pulse etoposide treatment supported the notion that RNF43 also functions DNA repair in mammalian cells.
These findings propose two possible functions of RNF43, either participating in NHEJ or removing the blockage of 5′ topo II adducts from DSB ends.
Related Results
Abstract 1658: Proteolytic processing pathways for topoisomerase covalent complexes
Abstract 1658: Proteolytic processing pathways for topoisomerase covalent complexes
Abstract
DNA topoisomerase II (Top2) is the target of several important anti-cancer agents, including doxorubicin and etoposide. Clinically active Top2 agents, terme...
Abstract 3580: Topoisomerase II mediated DNA damage generates unique classes of genome rearrangements
Abstract 3580: Topoisomerase II mediated DNA damage generates unique classes of genome rearrangements
Abstract
Topoisomerase 2 (Top2) is the target of active anti-cancer agents such as etoposide and doxorubicin. These drugs interfere with the Top2 catalytic cycle and...
Topoisomerase Assays
Topoisomerase Assays
AbstractTopoisomerases are enzymes that play essential roles in DNA replication, transcription, chromosome segregation, and recombination. All cells have two major forms of DNA top...
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract
Introduction: We are targeting DNA repair pathways to enhance existing chemoradiotherapeutic strategies against medulloblastoma (MB) and malignant glioma (M...
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study
Pharmacokinetic interaction between mitotane and etoposide in adrenal carcinoma: a pilot study
Background
The combination of mitotane and platinum-etoposide chemotherapy is a front-line treatment in metastatic adrenocortical carcinoma (ACC), although this...
Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry
Simultaneous determination of etoposide and its catechol metabolite in the plasma of pediatric patients by liquid chromatography/tandem mass spectrometry
AbstractThe anticancer drug etoposide is associated with leukemias with MLL gene translocations and other translocations as a treatment complication. The genotype of cytochrome P45...
Etoposide – inhalable fraction. Determination method in workplace air
Etoposide – inhalable fraction. Determination method in workplace air
Etoposide at room temperature is a fine white to yellow-brown crystalline odorless powder. Etoposide is one of the most widely used cytotoxic drugs and has strong antitumour activi...
Abstract 1757: Elesclomol (STA-4783) is a potent inhibitor of topoisomerase II
Abstract 1757: Elesclomol (STA-4783) is a potent inhibitor of topoisomerase II
Abstract
Elesclomol (STA-4783; N’1, N’3-dimethyl-N’1, N’3- bis(phenylcarbonothioyl)propanedihydrazide) is an anticancer drug that has received both fast track and or...

